Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4+ T Cell Immunity

Overview of attention for article published in Immunity, August 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 15 news outlets
twitter: 32 X users

patent: 4 patents
facebook: 1 Facebook page

Citations

dimensions_citation: 91 Dimensions

Readers on

mendeley: 182 Mendeley

Summary News X Patents Facebook Misc. Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Immune-modulating compounds

Grant US-11725041-B2

United States of America

IMMUNE STATUS BIOMARKERS AND USES THEREFOR

Application EP-3497448-A4

European Patent Office

GALECTIN IMMUNOTHERAPY

Application US-20190127474-A1

United States of America

IMMUNE-MODULATING COMPOUNDS

Application WO-2018027252-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.